JP2016502650A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502650A5
JP2016502650A5 JP2015538597A JP2015538597A JP2016502650A5 JP 2016502650 A5 JP2016502650 A5 JP 2016502650A5 JP 2015538597 A JP2015538597 A JP 2015538597A JP 2015538597 A JP2015538597 A JP 2015538597A JP 2016502650 A5 JP2016502650 A5 JP 2016502650A5
Authority
JP
Japan
Prior art keywords
time period
predetermined time
patient
concentration
estimate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015538597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502650A (ja
JP6335910B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/059424 external-priority patent/WO2014064585A1/en
Publication of JP2016502650A publication Critical patent/JP2016502650A/ja
Publication of JP2016502650A5 publication Critical patent/JP2016502650A5/ja
Application granted granted Critical
Publication of JP6335910B2 publication Critical patent/JP6335910B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015538597A 2012-10-25 2013-10-17 臨床決定支援に対する、血栓症に対する臨床的リスク因子及び分子マーカの組み合わされた使用 Expired - Fee Related JP6335910B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718242P 2012-10-25 2012-10-25
US61/718,242 2012-10-25
PCT/IB2013/059424 WO2014064585A1 (en) 2012-10-25 2013-10-17 Combined use of clinical risk factors and molecular markers for thrombosis for clinical decision support

Publications (3)

Publication Number Publication Date
JP2016502650A JP2016502650A (ja) 2016-01-28
JP2016502650A5 true JP2016502650A5 (enExample) 2016-12-01
JP6335910B2 JP6335910B2 (ja) 2018-05-30

Family

ID=49956255

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015538597A Expired - Fee Related JP6335910B2 (ja) 2012-10-25 2013-10-17 臨床決定支援に対する、血栓症に対する臨床的リスク因子及び分子マーカの組み合わされた使用

Country Status (7)

Country Link
US (1) US20150278470A1 (enExample)
EP (1) EP2912584B1 (enExample)
JP (1) JP6335910B2 (enExample)
CN (1) CN104756117B (enExample)
BR (1) BR112015009056A2 (enExample)
RU (1) RU2682622C2 (enExample)
WO (1) WO2014064585A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11568982B1 (en) 2014-02-17 2023-01-31 Health at Scale Corporation System to improve the logistics of clinical care by selectively matching patients to providers
US11114204B1 (en) 2014-04-04 2021-09-07 Predictive Modeling, Inc. System to determine inpatient or outpatient care and inform decisions about patient care
US10748659B2 (en) * 2015-03-10 2020-08-18 Abbott Cardiovascular Systems Inc. Method and system for predicting risk of thrombosis
US20160283686A1 (en) * 2015-03-23 2016-09-29 International Business Machines Corporation Identifying And Ranking Individual-Level Risk Factors Using Personalized Predictive Models
CN109310332A (zh) * 2016-04-07 2019-02-05 怀特安维创新有限责任公司 用于分析数字数据的方法
US11682495B2 (en) * 2016-10-13 2023-06-20 Carnegie Mellon University Structured medical data classification system for monitoring and remediating treatment risks
KR101865110B1 (ko) * 2016-11-21 2018-06-07 재단법인 아산사회복지재단 급성뇌경색 발생시점 추정시스템, 방법 및 프로그램
US20180181718A1 (en) * 2016-12-23 2018-06-28 King Abdulaziz University Interactive clinical decision support system
EP3422011A1 (en) * 2017-06-28 2019-01-02 Koninklijke Philips N.V. Parameter value estimation in coagulation system
WO2020054028A1 (ja) * 2018-09-13 2020-03-19 株式会社島津製作所 データ解析装置
CN109324188B (zh) * 2018-10-11 2022-04-08 珠海沃姆电子有限公司 一种精准化动态尿液测量方法和系统
US11922301B2 (en) * 2019-04-05 2024-03-05 Samsung Display Co., Ltd. System and method for data augmentation for trace dataset
US11710045B2 (en) 2019-10-01 2023-07-25 Samsung Display Co., Ltd. System and method for knowledge distillation
US11610679B1 (en) 2020-04-20 2023-03-21 Health at Scale Corporation Prediction and prevention of medical events using machine-learning algorithms
US12094582B1 (en) 2020-08-11 2024-09-17 Health at Scale Corporation Intelligent healthcare data fabric system
US12080428B1 (en) 2020-09-10 2024-09-03 Health at Scale Corporation Machine intelligence-based prioritization of non-emergent procedures and visits
JP7623120B2 (ja) 2020-10-01 2025-01-28 キヤノンメディカルシステムズ株式会社 診療支援システム
CN112767350B (zh) * 2021-01-19 2024-04-26 深圳麦科田生物医疗技术股份有限公司 血栓弹力图最大区间预测方法、装置、设备和存储介质
CN115188476B (zh) * 2022-07-20 2025-04-18 西安市红会医院(西安市骨科研究所) 基于遗传学特征预测骨折合并深静脉血栓风险的方法
JP7252688B1 (ja) * 2022-12-28 2023-04-05 株式会社AiCAN 児童相談業務を支援する情報処理方法、プログラム、情報処理システム

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007070A1 (en) * 1999-07-23 2001-02-01 The Scripps Research Institute Method for measuring coagulant factor activity in whole blood
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US8936588B2 (en) * 2001-09-21 2015-01-20 Fred Herz Patents, LLC Device and method for prevention and treatment of deep venous thrombosis
US20080255767A1 (en) * 2004-05-26 2008-10-16 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Method and Device For Detection of Splice Form and Alternative Splice Forms in Dna or Rna Sequences
WO2006052952A2 (en) * 2004-11-09 2006-05-18 The Brigham And Women's Hospital, Inc. System and method for determining whether to issue an alert to consider prophylaxis for a risk condition
WO2009142744A2 (en) 2008-05-20 2009-11-26 The University Of Vermont And State Agriculture College Predicting hemostatic risk; dependence on plasma composition

Similar Documents

Publication Publication Date Title
RU2015119520A (ru) Комбинированное использование клинических факторов риска и молекулярных маркеров тромбоза для поддержки принятия клинических решений
Jennions et al. Publication and related biases
JP2016500866A5 (enExample)
CN112107752A (zh) 血压预测方法与使用该方法的电子装置
WO2021065184A1 (ja) リハビリ計画装置、リハビリ計画システム、リハビリ計画方法、及びコンピュータ可読媒体
CN113614839A (zh) 使用统计偏好分析自动应用医生偏好工作流程
RU2017145636A (ru) Устройство, система и способ визуализации данных о пациенте
JP2017501465A5 (enExample)
JP2017523841A5 (enExample)
JP2017510350A5 (enExample)
US20160249863A1 (en) Health condition determination method and health condition determination system
RU2015119240A (ru) Система и способ медицинского обслуживания
CN104487975A (zh) 表现血液动力学不稳定性指数指标信息的方法
RU2015155566A (ru) Способ и система поддержки ухода за здоровьем
JP2010200840A5 (enExample)
CN106339624A (zh) 一种身份识别方法及装置
JP2019523926A (ja) 患者モニタのためのカスタマイズされた設定を提供するための方法及びシステム
CN104714574B (zh) 水温调节方法及装置
JP2015016098A5 (enExample)
CA3160255A1 (en) A method for determining a risk score for a patient
JP2022095099A5 (enExample)
JP2017536205A (ja) 透析治療のためのユーザー・インタフェース
CN108307044B (zh) 一种终端操作方法及设备
JP2008507784A (ja) 実行可能医療ガイドラインの実行をシミュレートするための意思決定支援システム
Ruppert et al. Overall success rate of a safe and efficacious drug: Results using six phase 1 designs, each followed by standard phase 2 and 3 designs